PharmaShots | Incisive News in 3 Shots

Subscribe Now

Withdraw

Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US

Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US

March 8, 2021

AstraZeneca to Withdraw Imfinzi Indication in Advanced Bladder Cancer in the US

AstraZeneca to Withdraw Imfinzi Indication in Advanced Bladder Cancer in the US

February 22, 2021

Amgen to Withdraw the ABP 710 (biosimilar- infliximab) MAA with European Medical Agency

Amgen to Withdraw the ABP 710 (biosimilar- infliximab) MAA with European Medical Agency

June 28, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us